What's on the web on your pursuit, hobbies, interests and worries

HemophiliaA news

Landenberg 11-year-old earns national award for hemophilia advocacy

Chester County Press - Sep 21, 2017
There are three kinds of hemophilia: Hemophilia A, also called classic hemophilia, which involves a clotting factor VIII deficiency; Hemophilia B, also called Christmas disease, which involves a clotting factor IX deficiency; and Hemophilia C, which is ...

PRAC Confirms No Difference in Risk Between Hemophilia A Drugs

Medscape - Sep 1, 2017
The European Medicines Agency (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) confirmed today its earlier decision that factor VIII medications for hemophilia A made from plasma and those made by recombinant DNA technology do notĀ ...

Regenxbio Likely to Add Dimension's DTX201 for Hemophilia A to Its Pipeline

Hemophilia News Today - Sep 18, 2017
The merger agreement, if finalized, will add Dimension's investigational drug candidates being developed to Regenxbio's pipeline, including DTX201 for the treatment of hemophilia A. DTX201 was being developed based on Regenxbio's proprietary NAVĀ ...

Hemophilia A - premium items on eBay

USED (VG) The Official Patient's Sourcebook on Hemophilia: A Revised and Updated


Hemophilia - A Medical Dictionary, Bibliography, and Annotated Research Guide to


Hemophilia: A Study in Hope & Reality by Alfred Katz (1970,HC,DJ)


>> Go to all great Hemophilia A deals on eBay

Hemophilia A pictures on the web

>> Show

Hemophilia A videos

Factor VIII and Hemophilia A

Donate here: http://www.aklectures.com/donate.php Website video link: http://www.aklectures.com/lecture/factor-viii-and-hemophilia-a Facebook link: ...

Hemophilia A & B

WVNCC Nursing concepts of health and illness 2.

A Novel Hemophilia A Therapy

Severe hemophilia A is often treated with infusions of factor VIII. But the infusions are burdensome, and antibodies develop in about 30% of patients.

Hemophilia A

Grand Rounds.

Assessing Recent Advances in Hemophilia A Management

Course Director, Guy Young, MD, discusses hemophilia A management in this CME/CE activity titled \